论文部分内容阅读
目的:研究华蟾素注射液外治法多途径治疗恶性肿瘤的临床疗效。方法:将76例恶性肿瘤患者随机分为观察组和对照组各38例,对照组患者采用常规治疗,观察组患者在常规治疗的基础上加用华蟾素注射液治疗,比较两组患者治疗前后肿瘤大小变化情况及并发症。结果:观察组患者并发症发生率显著低于对照组,差异具有统计学意义(P<0.05)。所有患者治疗后肿瘤体积均有所减小,且观察组患者肿瘤体积显著小于对照组,差异具有统计学意义(P<0.05)。结论:在常规治疗的基础上加用华蟾素注射液可缓解恶性肿瘤患者疼痛症状,抑制肿瘤生长,值得临床推广应用。
Objective: To study the curative effect of multi-pass therapy of cinobufacini injection on malignant tumor. Methods: A total of 76 patients with malignant tumor were randomly divided into observation group and control group, 38 cases in each group. Patients in control group were treated by conventional therapy. Patients in observation group were treated with cinobufacini injection on the basis of routine treatment. Before and after tumor size changes and complications. Results: The incidence of complications in the observation group was significantly lower than that in the control group, the difference was statistically significant (P <0.05). After treatment, the tumor volume of all patients decreased, and the tumor volume of observation group was significantly smaller than that of control group (P <0.05). Conclusion: Adding cinobufacini on the basis of routine treatment can relieve pain symptoms and inhibit tumor growth in patients with malignant tumors, which is worthy of clinical application.